Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia
Na Zhang, Tingting Geng, Zhangsheng Wang, Ruling Zhang, Tiefeng Cao, Joao Paulo Camporez, Shi-Ying Cai, Ya Liu, Luisa Dandolo, Gerald I. Shulman, Gordon G. Carmichael, Hugh S. Taylor, Yingqun Huang
Na Zhang, Tingting Geng, Zhangsheng Wang, Ruling Zhang, Tiefeng Cao, Joao Paulo Camporez, Shi-Ying Cai, Ya Liu, Luisa Dandolo, Gerald I. Shulman, Gordon G. Carmichael, Hugh S. Taylor, Yingqun Huang
View: Text | PDF
Research Article Endocrinology Metabolism

Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia

  • Text
  • PDF
Abstract

Excessive hepatic glucose production (HGP) contributes significantly to the hyperglycemia of type 2 diabetes; however, the molecular mechanism underlying this dysregulation remains poorly understood. Here, we show that fasting temporally increases the expression of H19 long noncoding RNA (lncRNA) in nondiabetic mouse liver, whereas its level is chronically elevated in diet-induced diabetic mice, consistent with the previously reported chronic hepatic H19 increase in diabetic patients. Importantly, liver-specific H19 overexpression promotes HGP, hyperglycemia, and insulin resistance, while H19 depletion enhances insulin-dependent suppression of HGP. Using genome-wide methylation and transcriptome analyses, we demonstrate that H19 knockdown in hepatic cells alters promoter methylation and expression of Hnf4a, a master gluconeogenic transcription factor, and that this regulation is recapitulated in vivo. Our findings offer a mechanistic explanation of lncRNA H19’s role in the pathogenesis of diabetic hyperglycemia and suggest that targeting hepatic H19 may hold the potential of new treatment for this disease.

Authors

Na Zhang, Tingting Geng, Zhangsheng Wang, Ruling Zhang, Tiefeng Cao, Joao Paulo Camporez, Shi-Ying Cai, Ya Liu, Luisa Dandolo, Gerald I. Shulman, Gordon G. Carmichael, Hugh S. Taylor, Yingqun Huang

×

Figure 4

Regulation of HNF4A promoter methylation via the H19/SAHH pathway.

Options: View larger image (or click on image) Download as PowerPoint
Regulation of HNF4A promoter methylation via the H19/SAHH pathway.
(A) S...
(A) Sequences of DMRs in the conserved promoter region of human and mouse Hnf4a. The 3 differentially methylated cytosine residues are indicated. The numbers on top of the sequences mark the positions of the indicated nucleotides in the chromosomes. The 3 differentially methylated cytosine residues are indicated in pink with arrowheads. (B) HepG2 cells were transfected with siCon, siH19, or siH19 + DEA. Genomic DNAs were extracted 15 hours later and analyzed by QMSP. (C) HepG2 cells were treated as described in B. RNAs were extracted 24 hours later and analyzed by qPCR. (D) RIP with anti-SAHH or preimmune IgGs from extracts of mouse livers. Top panel: RNA levels in immunoprecipitates were determined by qPCR. Levels of H19 and Gapdh mRNA are presented as fold enrichment in anti-SAHH relative to IgG immunoprecipitates. Bottom panel: relative RNA levels of H19 and Gapdh in mouse livers. Quantification is based on 3 independent experiments. Data are the mean ± SEM. *P < 0.05, **P < 0.01 based on Student t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts